Published in Mol Med Rep on April 08, 2011
Emerging markers of atherosclerosis before and after bariatric surgery. Obes Surg (2015) 1.55
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm (2013) 1.11
Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm (2013) 1.27
Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol (2003) 1.18
Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res (2004) 1.15
Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. Am J Physiol Cell Physiol (2005) 1.13
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide (2011) 0.96
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin Nutr (2007) 0.96
Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagul Fibrinolysis (2011) 0.95
Hemostasis alterations in metabolic syndrome (review). Int J Mol Med (2006) 0.95
Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity. Blood Coagul Fibrinolysis (2012) 0.91
Evaluation of metabolic syndrome in adults of Talca city, Chile. Nutr J (2008) 0.87
Role of PPARs in inflammatory processes associated with metabolic syndrome (Review). Mol Med Rep (2013) 0.84
Intervention with education and exercise reverses the metabolic syndrome in adults. J Am Soc Hypertens (2010) 0.84
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis. J Clin Lab Anal (2005) 0.84
Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals. J Diabetes Complications (2005) 0.81
Catabolic mediators as targets for cancer cachexia. Drug Discov Today (2003) 0.81
Gene expression of adipose tissue, endothelial cells and platelets in subjects with metabolic syndrome (Review). Mol Med Rep (2012) 0.80
Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Front Biosci (Schol Ed) (2010) 0.80
Patients with essential hypertension present higher levels of sE-selectin and sVCAM-1 than normotensive volunteers. Clin Exp Hypertens (2003) 0.78
The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways. FEBS Lett (2004) 0.77
Increased concentration of plasminogen activator inhibitor-1 and fibrinogen in individuals with metabolic syndrome. Mol Med Rep (2011) 0.77
Targets in clinical oncology: the metabolic environment of the patient. Front Biosci (2007) 0.77
Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis. Acta Diabetol (2010) 0.77
Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. Clin Rheumatol (2004) 0.77
Geographical Variation in Dementia Mortality in Italy, New Zealand, and Chile: The Impact of Latitude, Vitamin D, and Air Pollution. Dement Geriatr Cogn Disord (2016) 0.76
Effect of tomato industrial processing (different hybrids, paste, and pomace) on inhibition of platelet function in vitro, ex vivo, and in vivo. J Med Food (2013) 0.75
[Factors associated with dental consultation in children in Talca (Chile) and in Chilean immigrants in Montreal (Canada)]. Gac Sanit (2013) 0.75
High levels of hsCRP are associated with carbohydrate metabolism disorder. J Clin Lab Anal (2011) 0.75